Mometasone Furoate Accord-Uk

Mometasone furoate, the active ingredient in Mometasone Furoate Accord-Uk, is a glucocorticoid presented as a topical formulation for skin use. It is prescribed to manage inflammatory skin disorders such as psoriasis, atopic dermatitis, eczema and seborrheic dermatitis.

GNH USA supplies Mometasone Furoate Accord-Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical corticosteroid used to treat inflammatory skin conditions.

- Psoriasis: reduces scaling, erythema and plaque thickness. - Atopic dermatitis: alleviates itching, redness and inflammation. - Eczema: controls flare‑ups and promotes skin healing. - Seborrheic dermatitis: diminishes flaking and irritation on scalp and face.

Topical application of mometasone furoate may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site. - Dryness or peeling of the skin. - Redness or mild irritation. - Pruritus (itching). - Folliculitis or acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Secondary bacterial, fungal or viral skin infections. - Hypersensitivity reactions such as contact dermatitis. - Systemic effects like adrenal suppression with extensive use.

Mometasone furoate should be used according to medical guidance, with attention to specific safety considerations.

- Duration of use: limit prolonged therapy to reduce risk of skin atrophy. - Application area: avoid use on large surface areas or under occlusion unless directed. - Age restrictions: use in children only if prescribed by a qualified clinician. - Pre‑existing infections: treat bacterial, fungal or viral skin infections before initiating therapy. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Topical corticosteroids may interact with other agents applied to the skin or systemic medications.

Major Interactions (Avoid): - Systemic glucocorticoids: may increase risk of systemic corticosteroid effects. - Potent CYP3A4 inhibitors applied topically: can raise local drug concentration.

Moderate Interactions (Monitor Closely): - Antifungal or antibacterial creams: may alter skin barrier and affect absorption. - Phototherapy: combined use may increase skin irritation. - Immunosuppressants: monitor for heightened infection risk.